ReviewNeuropsychological characterization of hepatic encephalopathy
Introduction
The neuropsychological features of hepatic encephalopathy (HE) were described centuries ago. Hippocrates stated that “those who are mad on account of phlegm are quiet, but those on account of bile are vociferous, vicious, and do not keep quiet” [1]. It can be assumed that Hippocrates was describing a patient with acute liver injury. Patients with fulminant hepatic failure often present with agitation and restlessness. The behaviour of cirrhotics with HE, however, is dominated by significant psychomotor slowing. The first comprehensive study of the neuropsychiatric manifestations of HE was performed by Sherlock et al. in 1954 [2]. The authors described the clinical presentation of 18 patients with liver disease and neurological signs. In all subjects, clouding of consciousness was accompanied with a loss of facial expression and speech disturbances together with a disorder of the motor system represented by asterixis, tremor, increased tendon reflexes, increased muscle tone and ataxic gait. In a subsequent paper the same group [1] vividly described the disturbances of visual perception in patients with HE. They observed visual agnosia, macropsia, distortion and prolongation of the images, spatial disorientation and a predominance of visual hallucinations. Auditory, tactile, olfactory and gustatory hallucinations were noted in rare cases. The patients' moods fluctuated, while varying degrees of personality change could be observed in all patients even in the early stage of the disease.
Section snippets
‘Subclinical’ vs. ‘minimal’ encephalopathy
Since the 1970s, several groups have shown that many patients with cirrhosis who present without clinical signs of encephalopathy do significantly worse in psychometric tests when compared to healthy controls [3], [4], [5], [6], [7], [8], [9], [10]. They were regarded as suffering from ‘latent’ or ‘subclinical’ HE, a term that has been recently replaced by the term ‘minimal HE’ [11], [12]. A common finding of all studies was a worse performance of cirrhotic subjects in tests of psychomotor
A standardized battery to diagnose minimal HE
We decided to standardize and evaluate a ‘paper and pencil’ test battery for the assessment of minimal HE – the psychometric hepatic encephalopathy score (PHES) – that in accordance with the data of Hamster [11], [15] included seven tests: the line tracing test, the serial dotting test, the digit symbol test, NCTs A and B, the digit span test and the cancelling d-test [23]. The NCTs were included considering their widespread use as psychometric tests in cirrhotic patients. The digit span and
Conclusion
The results of this study have led us to recommend a test battery including NCTs A and B, the line drawing test, the serial dotting test and the digit symbol test for the assessment of minimal HE [24]. This battery examines motor speed and accuracy, visual perception, visuo-spatial orientation, visual construction, concentration, attention and to a lesser extent memory. None of the tests is a true classical test of attention. However, a successful performance of all tests requires an unimpaired
Acknowledgements
This paper is dedicated to Hans Schomerus, who died on 25 December 2000, a few days after we had finished this manuscript. All those who met him knew him as an exemplary human being, physician and scientist. We lost a friend and an outstanding personality. We will never forget him.
References (35)
- et al.
Portal-systemic encephalopathy. Neurological complications of liver disease
Lancet
(1954) - et al.
Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism
Gastroenterology
(1978) - et al.
Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy
Gastroenterology
(1984) “What's in a name?” Improving the care of cirrhotics
J Hepatol
(2000)- et al.
Fitness to drive in patients with cirrhosis and portal systemic shunting: a pilot study evaluating driving performance
J Hepatol
(1994) - et al.
The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis
J Hepatol
(1986) - et al.
Neurophysiological assessment of early hepatic encephalopathy
Electroenceph clin Neurophysiol
(1990) - et al.
The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis
Hepatology
(1996) - et al.
The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy
J Hepatol
(1998) - et al.
Cerebral ammonia-, H2O- and glucose-PET in cirrhotics with minimal hepatic encephalopathy (HE)
J Hepatol
(2000)
Screening of subclinical hepatic encephalopathy
J Hepatol
The neuropsychiatric syndrome associated with hepatic cirrhosis and an extensive portal collateral circulation
Q J Med
Method for measuring cerebral dysfunction in patients with liver disease
Br Med J
Cognitive deficits associated with chronic hepatic encephalopathy and their response to levodopa
J Neurol Neurosurg Psychiatry
Psychomotor performance defects in cirrhotic patients without overt encephalopathy
Arch Intern Med
Neuropsychiatric characteristics associated with primary biliary cirrhosis
Int J Psychiat Med
Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive
Dig Dis Sci
Cited by (647)
QuickStroop Predicts Time to Development of Overt Hepatic Encephalopathy and Related Hospitalizations in Patients With Cirrhosis
2024, Clinical Gastroenterology and HepatologyMinimal Hepatic Encephalopathy
2024, Clinics in Liver DiseaseHepatic Encephalopathy: Diagnostic Tools and Management Strategies
2023, Medical Clinics of North AmericaLongitudinal post-shunt outcomes in idiopathic normal pressure hydrocephalus with and without comorbid Alzheimer's disease
2023, Journal of the International Neuropsychological SocietyImproved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity
2024, Journal of Translational Medicine